7. Zhang X et al. Era of universal testing of microsatellite instability in colorectal cancer.World J Gastrointest Oncol. 2013;5(2):12–9 8. Tougeron D et al. Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability:...
7. Zhang X et al. Era of universal testing of microsatellite instability in colorectal cancer.World J Gastrointest Oncol. 2013;5(2):12–9 8. Tougeron D et al. Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study. J Natl Cancer Inst...
7. Zhang X et al. Era of universal testing of microsatellite instability in colorectal cancer.World J Gastrointest Oncol. 2013;5(2):12–9 8. Tougeron D et al. Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study. J Natl Cancer Inst...
7. Sargent, D.J., et al., Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol, 2010. 28(20): p. 3219-3226. 8. Zhu, L., et al., Microsatellite instability a...
7. Zhang X et al. Era of universal testing of microsatellite instability in colorectal cancer.World J Gastrointest Oncol. 2013;5(2):12–9 8. Tougeron D et al. Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study. J Natl Cancer Inst...
Abstract:Objective To explore the differences in mismatch repair (MMR) protein expression and clinical features between left-sided colon cancer and right-sided colon cancer. Methods The clinicopathological data of 302 colon cancer patients who underwent radical colon cancer treatment in the Department of...
[8] Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer[J].N Engl J Med2003, 349( 3) : 247-257. [9] Sargent DJ, Marsoni S, Monges G, et al Defective mismatch repair...
LBA24 Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: 3-year disease-free survival from NICHE-2doi:10.1016/j.annonc.2024.08.2263M. ChalabiL.D.W. van den DungenY.L. VerschoorS. BalduzziP.G.M. de GooyerN. Kok...
In a study evaluating the immunopeptidome of localised CRC and matched non-malignant colon from 37 CRC patients who underwent curative surgical resection, results demonstrated 45 non-mutated but potentially cancer specific peptides at the cell surface in the tumour tissue among 13 CRC cases (...
10.Ribic, C.M., Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer. 2003. 11.Eriksson, et al., Mismatch Repair/Microsatellite Instability Testing Practices among US Physicians Treating Patients with Advanced/Metastatic Colorectal...